DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gaudet D, Kereiakes DJ, McKenney JM. , et al.
Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials).
Am J Cardiol 2014;
114 (05) 711-715
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.